Download PDF
CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2021; 5(01): 003-010
DOI: 10.1055/s-0041-1729134
Original Article

Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Anatomical Aspects and Radiation Considerations from a Case Series of 210 Patients

Mohamed Shaker
1   Department of Diagnostic and Interventional Radiology, Ain Shams University, Cairo, Egypt
,
Essam Hashem
2   Department of Department of Diagnostic and Interventional Radiology, Ain Shams University, King’s College Hospital, Cairo, Egypt
,
Ahmed Abdelrahman
3   National Center for Radiation Research and Technology, Cairo, Egypt
,
Ahmed Okba
1   Department of Diagnostic and Interventional Radiology, Ain Shams University, Cairo, Egypt
› Author Affiliations
Subject Editor:
› Further Information
Also available at
   Permissions and Reprints

Abstract

Context Prostatic artery embolization (PAE) has been established as a safe and effective treatment option for symptomatic benign prostatic hyperplasia (BPH). Thorough knowledge of detailed prostatic artery (PA) anatomy is essential.

Aims The aim of this study was to provide a pictorial review of PA anatomy and prevalence of related anatomical variants, in addition to other anatomical and radiation dose considerations.

Settings and Design Case series and review of literature.

Materials and Methods We performed PAE for 210 patients from November 2015 to November 2020 under local anesthesia only. Anatomy, procedure duration, fluoroscopy time, radiation dose, technical success, and complications were analyzed.

Statistical Analysis Used Descriptive statistics were analyzed using Microsoft Excel software.

Results A total of 210 patients (420 sides) were analyzed. Double arterial supply on the same side was noted in 12 patients (5.7%). In 10 patients (4.7%), only a unilateral PA was identified. In two patients (0.9%), no PA could be identified. Frequencies of PA origins were calculated. Penile, rectal, and vesical anastomoses were identified with 79 (18.8%), 54 (12.9%), and 41 (9.8%) of PAs, respectively. Median skin radiation dose, procedure time, and fluoroscopy time were 505 mGy, 73 and 38 minutes, respectively. Complications occurred in nine patients (4.3%), none of them was major.

Conclusions Knowledge of PA anatomy is essential when treating BPH by PAE for optimum results. There is no enough evidence to support routine use of preoperative computed tomography angiography and intraoperative cone-beam computed tomography as means of improving safety or efficacy.

Keywords

prostate - embolization - prostatic artery embolization - angiographic anatomy - radiation - fluoroscopy time - prostatic anastomosis - nontarget embolization - cone-beam CT


Publication History

Article published online:
22 June 2021

© 2021. The Pan Arab Interventional Radiology Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 McWilliams JP, Bilhim TA, Carnevale FC. et al Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol 2019; 30 (05) 627-637.e1
    CrossrefPubMedGoogle Scholar
  • 2 Bhatia S, Sinha VK, Harward S, Gomez C, Kava BR, Parekh DJ. Prostate artery embolization in patients with prostate volumes of 80 ml or more: a single-institution retrospective experience of 93 patients. J Vasc Interv Radiol 2018; 29 (10) 1392-1398
    CrossrefPubMedGoogle Scholar
  • 3 de Assis AM, Moreira AM, de Paula Rodrigues VC. et al Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. J Vasc Interv Radiol 2015; 26 (01) 87-93
    CrossrefPubMedGoogle Scholar
  • 4 Bhatia S, Sinha VK, Kava BR. et al Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol 2018; 29 (01) 78-84.e1
    CrossrefPubMedGoogle Scholar
  • 5 Bagla S, Smirniotopoulos J, Orlando J, Piechowiak R. Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia. Cardiovasc Intervent Radiol 2017; 40 (11) 1694-1697
    CrossrefPubMedGoogle Scholar
  • 6 Russo GI, Kurbatov D, Sansalone S. et al Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities. Urology 2015; 86 (02) 343-348
    CrossrefPubMedGoogle Scholar
  • 7 Abt D, Hechelhammer L, Müllhaupt G. et al Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 2018; 361: k2338 DOI: 10.1136/bmj.k2338.
    CrossrefPubMedGoogle Scholar
  • 8 Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 2006; 50 (05) 969-979
    CrossrefPubMedGoogle Scholar
  • 9 Gao YA, Huang Y, Zhang R. et al Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate–a prospective, randomized, and controlled clinical trial. Radiology 2014; 270 (03) 920-928
    CrossrefPubMedGoogle Scholar
  • 10 Hashem E, Elsobky S, Khalifa M. Prostate artery embolization for benign prostate hyperplasia review: patient selection, outcomes, and technique. Semin Ultrasound CT MR 2020; 41 (04) 357-365
    CrossrefPubMedGoogle Scholar
  • 11 Carnevale FC, Soares GR, de Assis AM, Moreira AM, Harward SH, Cerri GG. Anatomical variants in prostate artery embolization: a pictorial essay. Cardiovasc Intervent Radiol 2017; 40 (09) 1321-1337
    CrossrefPubMedGoogle Scholar
  • 12 Shaker M, Hashem E. Benign prostatic hyperplasia treated entirely by unilateral prostate artery embolization. Arab J Interv Radiol 2020; 4 (01) 40 DOI: 10.4103/ajir.ajir_22_19.
    Article in Thieme ConnectGoogle Scholar
  • 13 Khalilzadeh O, Baerlocher MO, Shyn PB. et al Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 2017; 28 (10) 1432-1437.e3
    CrossrefPubMedGoogle Scholar
  • 14 Bilhim T, Tinto HR, Fernandes L. Martins Pisco J. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol 2012; 15 (04) 276-285
    CrossrefPubMedGoogle Scholar
  • 15 de Assis AM, Moreira AM, de Paula Rodrigues VC. et al Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol 2015; 38 (04) 855-861
    CrossrefPubMedGoogle Scholar
  • 16 du Pisanie J, Abumoussa A, Donovan K, Stewart J, Bagla S, Isaacson A. Predictors of prostatic artery embolization technical outcomes: patient and procedural factors. J Vasc Interv Radiol 2019; 30 (02) 233-240
    CrossrefPubMedGoogle Scholar
  • 17 Enderlein GF, Lehmann T, von Rundstedt FC. et al Prostatic artery embolization-anatomic predictors of technical outcomes. J Vasc Interv Radiol 2020; 31 (03) 378-387
    CrossrefPubMedGoogle Scholar
  • 18 Amouyal G, Pellerin O, Del Giudice C, Déan C, Thiounn N, Sapoval M. Bilateral arterial embolization of the prostate through a single prostatic artery: a case series. Cardiovasc Intervent Radiol 2017; 40 (05) 780-787
    CrossrefPubMedGoogle Scholar
  • 19 Amouyal G, Thiounn N, Pellerin O. et al Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol 2016; 39 (03) 367-375
    CrossrefPubMedGoogle Scholar
  • 20 Amouyal G, Chague P, Pellerin O. et al Safety and efficacy of occlusion of large extra-prostatic anastomoses during prostatic artery embolization for symptomatic BPH. Cardiovasc Intervent Radiol 2016; 39 (09) 1245-1255
    CrossrefPubMedGoogle Scholar
  • 21 Yu SCH, Cho C, Hung E. et al Case-control study of intra-arterial verapamil for intraprostatic anastomoses to extraprostatic arteries in prostatic artery embolization for benign prostatic hypertrophy. J Vasc Interv Radiol 2017; 28 (08) 1167-1176
    CrossrefPubMedGoogle Scholar
  • 22 Torres D, Costa NV, Pisco J, Pinheiro LC, Oliveira AG, Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm Embospheres. J Vasc Interv Radiol 2019; 30 (05) 638-644
    CrossrefPubMedGoogle Scholar
  • 23 Bhatia S, Sinha V, Bordegaray M, Kably I, Harward S, Narayanan G. Role of coil embolization during prostatic artery embolization: incidence, indications, and safety profile☆. J Vasc Interv Radiol 2017; 28 (05) 656-664.e3
    CrossrefPubMedGoogle Scholar
  • 24 de Assis AM, Moreira AM, Carnevale FC. Angiographic findings during repeat prostatic artery embolization. J Vasc Interv Radiol 2019; 30 (05) 645-651
    CrossrefPubMedGoogle Scholar
  • 25 Hacking N, Vigneswaran G, Maclean D. et al Technical and imaging outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) study: focusing on predictors of clinical success. Cardiovasc Intervent Radiol 2019; 42 (05) 666-676
    CrossrefPubMedGoogle Scholar
  • 26 Andrade G, Khoury HJ, Garzón WJ. et al Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol 2017; 28 (04) 517-521
    CrossrefPubMedGoogle Scholar
  • 27 Schott P, Katoh M, Fischer N, Freyhardt P. Radiation dose in prostatic artery embolization using cone-beam CT and 3D Roadmap Software. J Vasc Interv Radiol 2019; 30 (09) 1452-1458
    CrossrefPubMedGoogle Scholar
  • 28 Bagla S, Martin CP, van Breda A. et al Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol 2014; 25 (01) 47-52
    CrossrefPubMedGoogle Scholar
  • 29 Ray AF, Powell J, Speakman MJ. et al Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 2018; 122 (02) 270-282
    CrossrefPubMedGoogle Scholar
  • 30 Wang MQ, Duan F, Yuan K, Zhang GD, Yan J, Wang Y. Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology 2017; 282 (01) 271-280
    CrossrefPubMedGoogle Scholar
  • 31 Pisco JM, Bilhim T, Pinheiro LC. et al Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol 2016; 27 (08) 1115-1122
    CrossrefPubMedGoogle Scholar
  • 32 Garzón WJ, Andrade G, Dubourcq F. et al Prostatic artery embolization: radiation exposure to patients and staff. J Radiol Prot 2016; 36 (02) 246-254
    CrossrefPubMedGoogle Scholar
  • 33 Wang M, Guo L, Duan F. et al Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int 2016; 117 (01) 155-164
    CrossrefPubMedGoogle Scholar
  • 34 Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol 2016; 39 (01) 44-52
    CrossrefPubMedGoogle Scholar
  • 35 Chiaradia M, Radaelli A, Campeggi A. Bouanane M, De La Taille A, Kobeiter H. Automatic three-dimensional detection of prostatic arteries using cone-beam CT during prostatic arterial embolization. J Vasc Interv Radiol 2015; 26 (03) 413-417
    CrossrefPubMedGoogle Scholar
  • 36 Grosso M, Balderi A, Arnò M. et al Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients. Radiol Med (Torino) 2015; 120 (04) 361-368
    CrossrefPubMedGoogle Scholar